Description
1,2,3,4,5,6-hexabromocyclohexane directly inhibits a pocket within the JAK2 kinase domain, inhibiting autophosphorylation.
| Product Unit Size | Cost | Quantity | Stock |
|---|
1,2,3,4,5,6-hexabromocyclohexane directly inhibits a pocket within the JAK2 kinase domain, inhibiting autophosphorylation.
| Cas No. | 1837-91-8 |
|---|---|
| Purity | ≥98% |
| Formula | C6H6Br6 |
| Formula Wt. | 557.54 |
| IUPAC Name | 1,2,3,4,5,6-HEXABROMOCYCLOHEXANE |
| Store Temp | Ambient |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Sandberg E., Ma X., et al. Identification of 1,2,3,4,5,6-hexabromocyclohexane as a small molecule inhibitor of jak2 tyrosine kinase autophosphorylation [correction of autophophorylation]. J Med Chem. 48(7):2526-33 (2005). PMID: 15801842.
Endogenous peptide hormone, involved in water h...
PDE4 inhibitor.
H+/K+ ATPase inhibitor.
Synthetic ITC, erysolin analog.
Endogenous glycoprotein; lactoferrin agonist.
Inhibitor of CDK.
Bisphosphonate, chelating agent.
FIASMA, L-type Ca2+ channel blocker, D2 antagon...
Tyrosine kinase inhibitor.
Cathepsin inhibitor.
Piperadine phenothiazine; FIASMA, D1-5, histami...
Diterpene found in tobacco plants and cigarette...
PKC and S6 kinase substrate.
Polyphenolic compound present in black tea.
Camptothecin derivative; topoisomerase I inhibi...
Valsartan impurity
Cysteine adduct inducer, PARP-1 inhibitor.
Histamine H1 antagonist.
Imidzoline derivative; MDM2 inhibitor.
α7 and β4 nAChR agonist, α4β2 and α6β2 nA...